Tech Company Financing Transactions
iota Biosciences Funding Round
Astellas Venture Capital, Bold Capital Partners and Horizons Ventures participated in a $15 million Series A funding round for iota Biosciences. The round was announced on 12/29/2018.
Transaction Overview
Company Name
Announced On
12/29/2018
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
iota is using the funding to accelerate commercialization of its breakthrough millimeter-sized ultrasonic devices, which offer potentially revolutionary therapeutic applications for numerous chronic conditions from inflammation to motor disorders and eventually to cognitive impairment.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1936 University Ave. 355
Berkeley, CA 94704
USA
Berkeley, CA 94704
USA
Phone
Website
Email Address
Overview
iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning 'neural-dust' technology invented at the University of California, Berkeley, we are building a platform for the future of bioelectronic medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jose Carmena
Chief Executive Officer
Michel Maharbiz
VP - Bus. Development
James Hattersley
VP - Engineering
Josh Kay
Browse more venture capital transactions:
Prev: 12/29/2018: NantCell venture capital transaction
Next: 12/29/2018: Gobiquity venture capital transaction
Share this article
News on VC Transactions
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs